Page 31 - Covid19_Apr_30

CSIR-National Botanical Research Institute (NBRI), Lucknow have developed a herbal decongestant spray.
“The main reasons behind this problem include the accumulation of carbon dioxide and humidity in the inner cavity of the mask.When a person breathes in, this goes back to the lungs again. Repetition of this process over a period of time causes discomfort in breathing and congestion,” said Dr. Sharad Srivastava, Senior Principal Scientist, CSIR-NBRI, who led the team of researchers for this study.
“Herbal decongestant spray is a fine blend of four plant-based oils, but the names of these plants cannot be disclosed right now because of issues related to intellectual property.This product is developed based on the principles ofAyurveda and contains ingredients reported in traditional scriptures,” explained Dr Srivastava.
Website link:
https://vigyanprasar.gov.in/wp-content/uploads/Vigyan-Samachar-CSIR-News-3-24- Apr-20.pdf
http://nbri.res.in/
CSIR-IICT initiatives to reduce dependency for APIs and drug
intermediates
Active pharmaceutical ingredients (APIs) and intermediates are the key components of any drug that produces the intended effects. India is largely depended especially on China for supply of APIs and drug intermediates. Now Indian Institute of Chemical Technology (IICT), Hyderabad, is collaborating with another Hyderabad-based integrated pharmaceutical company, LAXAI Life Sciences,todevelopandmanufactureAPIsanddrugintermediates.Theinitiativemayhelpinreducing the dependency of the Indian pharmaceutical sector on Chinese imports of these ingredients.
IICT,a laboratory under the Council of Scientific and Industrial Research (CSIR),is working with LAXAI for synthesis of drugs being used in the fight against the CoronaVirus.The collaboration will primarily focus on Umifenovir, Remdesivir and a key intermediate of Hydroxy Chloroquine (HCQ).The collaboration will result in a cost-effective process with minimal dependency on China for key raw materials. In addition, Remdesivir, which has been previously administered to Ebola virus patients, is currently under clinical trials to evaluate efficacy and safety against COVID-19.
Website link:
https://vigyanprasar.gov.in/wp-content/uploads/Vigyan-Samachar-CSIR-News-1-24-Apr-20.pdf https://www.iictindia.org/
CIMAP’s Herbal products may boost immunity to avoid
infection
CIMAP, a constituent laboratory of the Council of Scientific and Industrial Research (CSIR), has decided to transfer the technology of its herbal products ‘CIM-Paushak’ and ‘Herbal Cough Syrup’ to the entrepreneurs and start-up companies. These two products were found to be effective in boosting the immunity of a person.Twelve valuable herbs including Puranva, Ashwagandha, Mulethi, Harad, Baheda and Sataver compounds have been used in both these products.
21